World Cancer Day: 4th February

Ministers, experts, and other delegates to discuss Global Vaccine Action Plan (GVAP), GAVI progress, non-communicable diseases, Millennium Development Goals, and other issues.

In a global effort to protect more women from cervical cancer and millions of children from a premature death or life-long disabilities, GAVI will include HPV and combined measles-rubella vaccines in its portfolio for the first time as it opens a new round of applications. [Français]

Seth Berkley speech underlines broader consequences of vaccination for economic development.

New York-based Women Deliver highlights potential benefits of HPV vaccine for as many as 28 million girls in developing countries by 2020. [日本語]

Not many scientists live to see vaccine development from basic science all the way through to clinical trials and country introductions, says Professor Ian Frazer, inventor of a vaccine against human papillomavirus (HPV), the infection that causes cervical cancer.

The GAVI Alliance prioritised support for HPV vaccines as part of its new vaccine investment strategy. [Français] [Deutsch]

Non-communicable diseases ( NCDs ) are the leading causes of death globally. NCDs killed 36 million people in 2008, representing 63 % of global deaths, principally from cardiovascular diseases, diabetes, cancer and chronic respiratory infections. [Deutsch] [Français]

The Report aims to present the evidence that supports the case for expanded access to Cancer Care and Control (CCC), describe innovative models for achieving this goal, and provide a blueprint for future action in resource constrained settings as part of efforts to improve health systems strengthening. The Report draws on the work of more than 115 authors and contributors, includingmembers of the GTF.CCC and its Technical Advisory Committee, as well as patients and representatives of academic, civil society, private sector, multi-lateral and govern mental institutions from countries at all resource levels.